Advertisement

Supply Chain



The Food and Drug Administration recently approved Vemlidy, a once-daily treatment for patients with compensated liver disease caused by chronic hepatitis B virus.

As the healthcare industry moves from a fee-for-service model to value-based care, controlling spend on high-value supplies is more critical than ever. The use of automation and data analytics allows supply chain leaders to transform data into actionable insights that…

Advertisement

Most Read

Advertisement
Advertisement